Contents

Search


highly active antiretroviral therapy (HAART)

Combinations of antiretroviral agents used in treatment of HIV1. Indications: - retroviral infection - HIV infection - HIV1 infection - HIV infection during pregnancy is always an indication for HAART - race NOT a factor in treatment outcomes [2] Dosage: 1) one antiretroviral protease inhibitor + 2 NRTI 2) one NNRTI plus 2 NRTI 3) three NRTIs 4) two antiretroviral protease inhibitors + 2 NRTI [4] zidovudine should be incorporated in all HAART regimens do NOT use stavudine since combination of zidovudine & stavudine is contraindicated high-dose multivitamin not helpful, perhaps harmful [5] Adverse effects: 1) HAART may not be associated with better outcomes [1] 2) immune reconstitution inflammatory syndrome 3) paradoxical worsening of underlying opportunistic infection 4) increased risk of cardiovascular disease [4]

Related

antiretroviral agent

General

antiretroviral therapy (ART)

References

  1. The Antiretroviral Therapy (ART) Cohort Collaboration. HIV treatment response and prognosis in Europe and North America in the first decade of highly active retroviral therapy. A collaborative analysis. Lancet 2006, 36:451 PMID: 16890831
  2. Silverberg MJ et al, Effectiveness of highly-active antiretroviral therapy by therapy by race/ethnicity. AIDS 2006, 20:1431 PMID: 16847408
  3. Sackoff JE et al, Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City Ann Intern Med 2006, 145:397 PMID: 16983127 - Aberg JA The changing face of HIV care: Common things really are common. Ann Intern Med 2006, 145:463 PMID: 16983135
  4. Medical Knowledge Self Assessment Program (MKSAP) 14, 15 American College of Physicians, Philadelphia 2006, 2009
  5. Isanaka S et al Effect of High-Dose vs Standard-Dose Multivitamin Supplementation at the Initiation of HAART on HIV Disease Progression and Mortality in Tanzania A Randomized Controlled Trial JAMA. 2012;308(15):1535-1544. PMID: 23073950 http://jama.jamanetwork.com/article.aspx?articleid=1383231